Paroxysmal dyskinesias as a paradigm of paroxysmal movement disorders

Current Opinion in Neurology

Volumn 13, Issue 4, 2000, Pages 457-462

  Vidailhet, Marie ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHOREOATHETOSIS; CHROMOSOME 16; CONVULSION; DIFFERENTIAL DIAGNOSIS; DYSKINESIA; GENETIC LINKAGE; HUMAN; MOTOR DYSFUNCTION; SPASTICITY;

ATHETOSIS; CHOREA; CIRCADIAN RHYTHM; DOPAMINE; DYSKINESIAS; HUMANS; INFANT, NEWBORN; ION CHANNELS; MOVEMENT DISORDERS; SEIZURES;

EID: 0033851903     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200008000-00015     Document Type: Article

References (56)

1. Autosomal dominant nocturnal frontal lobe epilepsy. A video-polysomnographic and genetic appraisal of 40 patients and delineation of the epileptic syndrome
2. Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases
3. Electroclinical picture of autosomal dominant nocturnal frontal lobe epilepsy in a Japanese family
4. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2
5. Autosomal dominant nocturnal frontal-lobe epilepsy: Genetic heterogeneity and evidence for a second locus at 15q24
6. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy
7. Autosomal dominant nocturnal frontal lobe epilepsy in a Spanish family with a Ser252Phe mutation in the CHRNA4 gene
8. Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases including one autopsy
9. Paroxysmal dyskinesias: Clinical features and classification
10. Clinical manifestations of 20 Taiwanese patients with paroxysmal kinesigenic dyskinesia
11. Multicenter study of paroxysmal dyskinesias in Japan-clinical and pedigree analysis
12. Familial paroxysmal choreoathetosis
13. Familial paroxysmal dystonic choreoathetosis and its differentiation from related syndromes
14. Familial infantile convulsions and paroxysmal choreoathetosis: A new neurological syndrome linked to the pericentromeric region of human chromosome 16
15. Paroxysmal kinesigenic choreoathetosis: A report of 26 patients
16. A locus for paroxysmal kinesigenic dyskinesia maps to human chromosome 16
17. A family with an atonic variant of paroxysmal kinesigenic choreoathetosis and hypercalcitoninemia
18. Paroxysmal kinesigenic dyskinesia in infancy
19. Paroxysmal dyskinesia and gonadal sex hormones
20. Familial paroxysmal dystonic choreoathetosis: Clinical findings in a large Japanese family and genetic linkage to 2q
21. Paroxysmal choreoathetosis: An epileptic or non epileptic disorder?
22. Familial paroxysmal kinesigenic choreoathetosis: An electrophysiologic and genotypic analysis
23. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family
24. Genetic localization of the familial adult myoclonic epilepsy (FAME) gene to chromosome 8q24
25. Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1
26. Association of infantile convulsions with paroxysmal dyskinesias (ICCA syndrome): Confirmation of linkage to human chromosome 16p12-q12 in a Chinese family
27. Identification and cloning of putative human neuronal voltage-gated calcium channel gamma-2 and gamma-3 subunits: Neurologic implications
28. The paroxysmal dyskinesias
29. Gabapentin for familial paroxysmal dystonic choreoathetosis
30. Paroxysmal dystonic choreoathetosis: Genetic linkage studies in a British family
31. Paroxysmal exercise-induced dystonia: Eight new sporadic cases and a review of the literature
32. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1P, probably within 2cM between D15443 and D15197
33. Paroxysmal dystonic choreoathetosis: Tight linkage to chromosome 2
34. Paroxysmal dystonic choreoathetosis linked to chromosome 2q: Clinical analysis and proposed pathophysiology
35. A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q
36. Mutational analysis of the anion exchanger 3 gene in familial paroxysmal dystonic choreoathetosis linked to chromosome 2q
37. Gene locus FPD1 of the dystonic Mount-reback type of autosomal dominant paroxysmal choreoathetosis
38. Autosomal recessive rolandic epilepsy with paroxysmal exercise-induced dystonia and writer's cramp: Delineation of the syndrome and gene mapping to chromosome 16p12-11.2
39. Channelopathies: Ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system
40. Ion channel genes and human neurological disease: Recent progress, prospects, and challenges
41. Alterations in spontaneous single unit activity of striatal subdivisions during ontogenesis in mutant dystonic hamsters
42. In vivo extracellular electrophysiology of pallidal neurons in dystonic and nondystonic hamsters
43. 3H)win 35,428 binding to the dopamine transporter in a hamster model of idiopathic paroxysmal choreoathetosis
44. 11C)dihydrotetrabenazine PET imaging in familial paroxysmal dystonic choreoathetosis
45. Paroxysmal dyskinesia in patients with HIV infection
46. Paroxysmal dystonia in Behcet's disease
47. Exercise induced steroid dependent dystonia, ataxia, and alternating hemiplegia associated with epilepsy
48. The paroxysmal dyskinesia
49. Movement disorders in multiple sclerosis
50. An open label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis
51. Positive symptoms in multiple sclerosis: Their treatment with sodium channel blockers, lidocaine and mexiletine
52. Association of ipsilateral motor automatisms and contralateral dystonic posturing: A clinical feature differentiating medial from neocortical temporal lobe epilepsy
53. Pseudoseizures and other non epileptic paroxysmal disorders in children and adolescents
54. Hyperekplexia phenotype due to compound heterozygosity for GLRA1 gene mutations
55. Alternating hemiplegia of childhood and oculomotor anomalies
56. CACNA1A mutations: Hemiplegic migraine, episodic ataxia type 2, and the others